Use of Sedatives and Neuromuscular-Blocking Agents in Mechanically Ventilated Patients with COVID-19 ARDS.

Amédée Ego Lorenzo PelusoJulie GorhamAlberto DiosdadoGiovanni RestucciaJacques CreteurFabio Silvio Taccone

Published in: Microorganisms (2021)

The duration and consumption of sedatives and NMBA was significantly increased in patients with COVID-19 related ARDS than in non-COVID ARDS. Different sedation strategies and protocols might be needed in COVID-19 patients with ARDS, with potential implications on long-term complications and drugs availability.

Keyphrases

acute respiratory distress syndrome
mechanical ventilation
extracorporeal membrane oxygenation
coronavirus disease
sars cov
intensive care unit
risk factors